Additionally, chemotherapy triggers cathepsin B release in myeloid-derived suppressor cells, activating the NLRP3 inflammasome leading to MDSC-derived IL-1β and angiogenesis and promoting tumor growth and metastasis (75, 76). The gene discussed is NLRP3; the disease is neoplasm.